Results 161 to 170 of about 25,711 (214)

SARS-CoV-2 coinfection in patients with invasive pulmonary aspergillosis: clinical characteristics and prognosis. [PDF]

open access: yesAnn Clin Microbiol Antimicrob
Xie M   +8 more
europepmc   +1 more source

Mucorales PCR Testing in Respiratory and Biopsy Samples From Immunocompromised Patients With Invasive Pulmonary Aspergillosis and Other Mold Infections: Results From a Multicenter ECMM Study. [PDF]

open access: yesOpen Forum Infect Dis
Sedik S   +13 more
europepmc   +1 more source

Invasive Pulmonary Aspergillosis

Respiration, 2002
<i>Background:</i> Invasive pulmonary aspergillosis usually occurs in immunocompromised patients. Mild abnormality of host defence is usually present in the chronic necrotising form of the disease. Acute aspergillus pneumonia usually affects patients who are seriously immunocompromised.
Sabina Skrgat, Kristan   +2 more
  +7 more sources

Invasive pulmonary aspergillosis/pseudomonas

BMJ Case Reports, 2021
A 47-year-old Caucasian man on long-standing antifungal therapy for chronic necrotising aspergillosis and a history of recurrent pseudomonas pneumonias presented to the outpatient pulmonary clinic with dyspnoea and chest discomfort for 3 days. A CT angiography of the chest demonstrated angioinvasion from the previously noted left upper lobe cavitary ...
Menaka Mahendran, Daniel Urbine
openaire   +2 more sources

Invasive pulmonary aspergillosis

Expert Review of Anti-infective Therapy, 2005
In susceptible patients, invasive aspergillosis has a high incidence and a mortality of up to 80%. The diagnosis of this condition is difficult, especially in the early stages of the disease and, as a consequence, antifungal therapy, despite its expense and toxicity, is often initiated empirically.
S R, Doffman   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy